{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T03:36:42Z","timestamp":1783741002370,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,4]]},"DOI":"10.7759\/cureus.87264","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T08:16:47Z","timestamp":1751617007000},"source":"Crossref","is-referenced-by-count":1,"title":["Hypereosinophilic Syndrome in a Patient With Cystic Fibrosis: A Rare Case of Cardiac Involvement and Response to Mepolizumab"],"prefix":"10.7759","author":[{"given":"Moshe","family":"Heching","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzlil","family":"Grinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"Hamdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lev","family":"Freidkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimon","family":"Izhakian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maayan","family":"Huberman Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mordechai R","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27287","article-title":"World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management","volume":"99","author":"Shomali W","year":"2024","unstructured":"Shomali W, Gotlib J. World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management. Am J Hematol. 2024, 99:946-68. 10.1002\/ajh.27287","journal-title":"Am J Hematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/all.16463","article-title":"Hypereosinophilia and hypereosinophilic syndromes: first findings from a nationwide multicenter cohort","volume":"80","author":"Lef\u00e8vre G","year":"2025","unstructured":"Lef\u00e8vre G, Bleuse S, Puyade M, et al.. Hypereosinophilia and hypereosinophilic syndromes: first findings from a nationwide multicenter cohort. Allergy. 2025, 80:1100-10. 10.1111\/all.16463","journal-title":"Allergy"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2022.05.019","article-title":"The hypereosinophilic syndrome - an unusual cause of myocarditis and cardioembolic strokes","volume":"364","author":"Ryan D","year":"2022","unstructured":"Ryan D, Inamullah O, El Husseini N, Wang E, Selim MA, Feng W. The hypereosinophilic syndrome - an unusual cause of myocarditis and cardioembolic strokes. Am J Med Sci. 2022, 364:661-8. 10.1016\/j.amjms.2022.05.019","journal-title":"Am J Med Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2025.46.240106","article-title":"Efficacy of anti-interleukin 5 therapy in hypereosinophilic syndrome: an updated systematic review and meta-analysis","volume":"46","author":"Masood S","year":"2025","unstructured":"Masood S, Paracha MR, Ahmed S, et al.. Efficacy of anti-interleukin 5 therapy in hypereosinophilic syndrome: an updated systematic review and meta-analysis. Allergy Asthma Proc. 2025, 46:e24-32. 10.2500\/aap.2025.46.240106","journal-title":"Allergy Asthma Proc"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202108-1889OC","article-title":"Characterization of eosinophilic bronchiectasis: a European multicohort study","volume":"205","author":"Shoemark A","year":"2022","unstructured":"Shoemark A, Shteinberg M, De Soyza A, et al.. Characterization of eosinophilic bronchiectasis: a European multicohort study. Am J Respir Crit Care Med. 2022, 205:894-902. 10.1164\/rccm.202108-1889OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13164932","article-title":"Eosinophilic bronchiectasis: prevalence, severity, and associated features-a cohort study","volume":"13","author":"Campisi R","year":"2024","unstructured":"Campisi R, Nolasco S, Mancuso M, et al.. Eosinophilic bronchiectasis: prevalence, severity, and associated features-a cohort study. J Clin Med. 2024, 13:4932. 10.3390\/jcm13164932","journal-title":"J Clin Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-023-00668-w","article-title":"Elevated eosinophil counts in acute exacerbations of bronchiectasis: unveiling a distinct clinical phenotype","volume":"202","author":"Chen W","year":"2024","unstructured":"Chen W, Ran S, Li C, Li Z, Wei N, Li J, Li N. Elevated eosinophil counts in acute exacerbations of bronchiectasis: unveiling a distinct clinical phenotype. Lung. 2024, 202:53-61. 10.1007\/s00408-023-00668-w","journal-title":"Lung"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2022.03.034","article-title":"Clinical profile and treatment in hypereosinophilic syndrome variants: a pragmatic review","volume":"10","author":"Requena G","year":"2022","unstructured":"Requena G, van den Bosch J, Akuthota P, Kovalszki A, Steinfeld J, Kwon N, Van Dyke MK. Clinical profile and treatment in hypereosinophilic syndrome variants: a pragmatic review. J Allergy Clin Immunol Pract. 2022, 10:2125-34. 10.1016\/j.jaip.2022.03.034","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/all.15544","article-title":"Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes","volume":"78","author":"Valent P","year":"2023","unstructured":"Valent P, Klion AD, Roufosse F, et al.. Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes. Allergy. 2023, 78:47-59. 10.1111\/all.15544","journal-title":"Allergy"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2022000367","article-title":"Approach to the patient with suspected hypereosinophilic syndrome","volume":"2022","author":"Klion AD","year":"2022","unstructured":"Klion AD. Approach to the patient with suspected hypereosinophilic syndrome. Hematology Am Soc Hematol Educ Program. 2022, 2022:47-54. 10.1182\/hematology.2022000367","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.09.023","article-title":"Eosinophilic myocarditis: characteristics, treatment, and outcomes","volume":"70","author":"Brambatti M","year":"2017","unstructured":"Brambatti M, Matassini MV, Adler ED, Klingel K, Camici PG, Ammirati E. Eosinophilic myocarditis: characteristics, treatment, and outcomes. J Am Coll Cardiol. 2017, 70:2363-75. 10.1016\/j.jacc.2017.09.023","journal-title":"J Am Coll Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12968-023-00979-0","article-title":"Cardiac magnetic resonance in histologically proven eosinophilic myocarditis","volume":"25","author":"P\u00f6yh\u00f6nen P","year":"2023","unstructured":"P\u00f6yh\u00f6nen P, R\u00e5gback J, M\u00e4yr\u00e4np\u00e4\u00e4 MI, Nordenswan HK, Lehtonen J, Shenoy C, Kupari M. Cardiac magnetic resonance in histologically proven eosinophilic myocarditis. J Cardiovasc Magn Reson. 2023, 25:79. 10.1186\/s12968-023-00979-0","journal-title":"J Cardiovasc Magn Reson"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2020-317202","article-title":"Hypereosinophilic syndrome: considerations for the cardiologist","volume":"108","author":"Bondue A","year":"2022","unstructured":"Bondue A, Carpentier C, Roufosse F. Hypereosinophilic syndrome: considerations for the cardiologist. Heart. 2022, 108:164-71. 10.1136\/heartjnl-2020-317202","journal-title":"Heart"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-221794","article-title":"2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis","volume":"81","author":"Grayson PC","year":"2022","unstructured":"Grayson PC, Ponte C, Suppiah R, et al.. 2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis. Ann Rheum Dis. 2022, 81:309-14. 10.1136\/annrheumdis-2021-221794","journal-title":"Ann Rheum Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.09.036","article-title":"Drug reaction with eosinophilia and systemic symptoms may occur within 2\u00a0weeks of drug exposure: a retrospective study","volume":"82","author":"Soria A","year":"2020","unstructured":"Soria A, Bernier C, Veyrac G, Barbaud A, Puymirat E, Milpied B. Drug reaction with eosinophilia and systemic symptoms may occur within 2\u00a0weeks of drug exposure: a retrospective study. J Am Acad Dermatol. 2020, 82:606-11. 10.1016\/j.jaad.2019.09.036","journal-title":"J Am Acad Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2019.40.4264","article-title":"Workup for eosinophilia","volume":"40","author":"Guo C","year":"2019","unstructured":"Guo C, Bochner BS. Workup for eosinophilia. Allergy Asthma Proc. 2019, 40:429-32. 10.2500\/aap.2019.40.4264","journal-title":"Allergy Asthma Proc"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2022.10.027","article-title":"Significance and potential role of eosinophils in non-cystic fibrosis bronchiectasis","volume":"11","author":"Guan WJ","year":"2023","unstructured":"Guan WJ, Oscullo G, He MZ, Xu DY, G\u00f3mez-Olivas JD, Martinez-Garcia MA. Significance and potential role of eosinophils in non-cystic fibrosis bronchiectasis. J Allergy Clin Immunol Pract. 2023, 11:1089-99. 10.1016\/j.jaip.2022.10.027","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/imr.70009","article-title":"The cystic fibrosis transmembrane conductance receptor brakes allergic airway inflammation","volume":"330","author":"Cook DP","year":"2025","unstructured":"Cook DP, Peebles RS Jr. The cystic fibrosis transmembrane conductance receptor brakes allergic airway inflammation. Immunol Rev. 2025, 330:e70009. 10.1111\/imr.70009","journal-title":"Immunol Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1080\/080352502760272759","article-title":"Cushing's syndrome due to pharmacological interaction in a cystic fibrosis patient","volume":"91","author":"Main KM","year":"2002","unstructured":"Main KM, Skov M, Sillesen IB, Dige-Petersen H, M\u00fcller J, Koch C, Lanng S. Cushing's syndrome due to pharmacological interaction in a cystic fibrosis patient. Acta Paediatr. 2002, 91:1008-11. 10.1080\/080352502760272759","journal-title":"Acta Paediatr"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000407.pub4","article-title":"Oral steroids for long-term use in cystic fibrosis","volume":"2015","author":"Cheng K","year":"2015","unstructured":"Cheng K, Ashby D, Smyth RL. Oral steroids for long-term use in cystic fibrosis. Cochrane Database Syst Rev. 2015, 2015:CD000407. 10.1002\/14651858.CD000407.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.08.037","article-title":"Efficacy and safety of mepolizumab in hypereosinophilic syndrome: a\u00a0phase III, randomized, placebo-controlled trial","volume":"146","author":"Roufosse F","year":"2020","unstructured":"Roufosse F, Kahn JE, Rothenberg ME, et al.. Efficacy and safety of mepolizumab in hypereosinophilic syndrome: a\u00a0phase III, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2020, 146:1397-405. 10.1016\/j.jaci.2020.08.037","journal-title":"J Allergy Clin Immunol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/jleuko\/qiae152","article-title":"Hypereosinophilic syndrome response to mepolizumab in the setting of a compassionate use program","volume":"116","author":"Coussement G","year":"2024","unstructured":"Coussement G, Catherine J, Roufosse F. Hypereosinophilic syndrome response to mepolizumab in the setting of a compassionate use program. J Leukoc Biol. 2024, 116:1021-32. 10.1093\/jleuko\/qiae152","journal-title":"J Leukoc Biol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2025.03.016","article-title":"Long-term efficacy and safety of benralizumab treatment for PDGFRA-negative hypereosinophilic syndrome","volume":"13","author":"Kuang FL","year":"2025","unstructured":"Kuang FL, Makiya MA, Ware JM, et al.. Long-term efficacy and safety of benralizumab treatment for PDGFRA-negative hypereosinophilic syndrome. J Allergy Clin Immunol Pract. 2025, 13:1421-1429.e2. 10.1016\/j.jaip.2025.03.016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-023-02918-9","article-title":"Low-dose anti-IL 5 treatment in idiopathic hypereosinophilic syndrome: towards a precision medicine approach for remission maintenance","volume":"18","author":"Caminati M","year":"2023","unstructured":"Caminati M, Maule M, Benoni R, et al.. Low-dose anti-IL 5 treatment in idiopathic hypereosinophilic syndrome: towards a precision medicine approach for remission maintenance. Orphanet J Rare Dis. 2023, 18:302. 10.1186\/s13023-023-02918-9","journal-title":"Orphanet J Rare Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/370882-hypereosinophilic-syndrome-in-a-patient-with-cystic-fibrosis-a-rare-case-of-cardiac-involvement-and-response-to-mepolizumab","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T08:16:47Z","timestamp":1751617007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/370882-hypereosinophilic-syndrome-in-a-patient-with-cystic-fibrosis-a-rare-case-of-cardiac-involvement-and-response-to-mepolizumab"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,4]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.87264","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,4]]}}}